SCHEMBL30926403

SCHEMBL30926403

CC1(C)OB(c2ccc3c(c2)C2(CCC2)NC3=O)OC1(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 5/20 0.41
▸ LPL P06858 7/20 0.36
▸ LIPG Q9Y5X9 7/20 0.36
▸ PRMT5 O14744 1/20 0.35
▸ WDR77 Q9BQA1 1/20 0.35
▸ CA1 P00915 2/20 0.34
▸ CA2 P00918 2/20 0.34
▸ CA9 Q16790 2/20 0.34
▸ CA12 O43570 1/20 0.34
▸ CA3 P07451 1/20 0.34
▸ CA4 P22748 1/20 0.34
▸ CA6 P23280 1/20 0.34
▸ CA5A P35218 1/20 0.34
▸ CA7 P43166 1/20 0.34
▸ CA14 Q9ULX7 1/20 0.34
▸ CA5B Q9Y2D0 1/20 0.34
▸ HRH3 Q9Y5N1 1/20 0.33
▸ CSF1R P07333 1/20 0.33
▸ P2RX7 Q99572 1/20 0.33
▸ IDO1 P14902 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12077723 0.94 BACE1 (0.42) BACE1LPLLIPGPRMT5WDR77
SCHEMBL30416516 0.83 BACE1 (0.40) BACE1LPLLIPGPRMT5WDR77
SCHEMBL16006501 0.83 BACE1 (0.40) BACE1LPLLIPGPRMT5WDR77
SCHEMBL24681504 0.83 MKNK1 (0.40) BACE1LPLLIPGPRMT5WDR77
SCHEMBL29964196 0.83 MKNK1 (0.40) BACE1LPLLIPGPRMT5WDR77
SCHEMBL30935204 0.81 BACE1 (0.37) BACE1LPLLIPGPRMT5WDR77
SCHEMBL12078031 0.77 BACE1 (0.38) BACE1LPLLIPGPRMT5WDR77
SCHEMBL12617055 0.77 LPL (0.41) BACE1LPLLIPGCA1CA2
SCHEMBL30926385 0.77 CDC7 (0.39) BACE1LPLLIPGPRMT5WDR77
SCHEMBL12078315 0.77 CDC7 (0.39) BACE1LPLLIPGPRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4626423-A1 CDK INHIBITORS AND METHODS AND USE THEREOF Relay Therapeutics, Inc. (US) 2025-10-08 — — EP disclosed
WO-2024119122-A1 CDK INHIBITORS AND METHODS AND USE THEREOF RELAY THERAPEUTICS, INC. (US) 2024-06-06 — — WO disclosed
Send feedback